Up-front fecal diversion can palliate emergent symptoms related to locally advanced rectal cancer (LARC) allowing patients to receive neoadjuvant chemoradiation therapy (nCRT). We analyzed outcomes of pretreatment-diverted LARC patients relative to nondiverted patients to define the impact of this management strategy. We retrospectively collected data on 103 LARC patients treated with nCRTand surgery. Medical records were reviewed for patient characteristics, staging, treatment plan, and outcomes. Thirteen LARC patients underwent pretreatment diversion for urgent symptoms and 90 LARC patients proceeded directly to nCRT. In all, 50 per cent of diverted patients presented with T4 tumor compared with 14 per cent in the nondiverted patients (P = 0.003). Diverted patients experienced a delay in time-to-treatment initiation of 12 days, although this difference was not statistically significant. Similar rates of chemoradiation and surgical toxicities were observed. Even though diverted patients demonstrated less pathologic response to nCRT compared with nondiverted patients (P = 0.04), there was no significant difference in overall survival. In conclusion, our study demonstrates the effectiveness of up-front fecal diversion at managing emergent obstructive symptoms related to advanced rectal cancer without additional complications, allowing patients to proceed with nCRT followed by radical surgery.
SauerR., BeckerH., HohenbergerW.Preoperative versus postoperative chemoradiotherapy for rectal cancer.N Engl J Med2004; 351: 1731–40.
3.
Glynne-JonesR., WallaceM., LivingstoneJ.I.Complete clinical response after preoperative chemoradiation in rectal cancer: is a “wait and see” policy justified?Dis Colon Rectum2008; 51: 10–19, discussion 19–20.
4.
DuldulaoM.P., LeeW., LeM.Surgical complications and pathologic complete response after neoadjuvant chemoradiation in locally advanced rectal cancer.Am Surg2011; 77: 1281–5.
5.
CraneC.H., SkibberJ.M., FeigB.W.Response to pre-operative chemoradiation increases the use of sphincter-preserving surgery in patients with locally advanced low rectal carcinoma.Cancer2003; 97: 517–24.
6.
GuillemJ.G., ChessinD.B., CohenA.M.Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer.Ann Surg2005; 241: 829–836; discussion 836–828.
7.
KapiteijnE., MarijnenC.A., NagtegaalI.D.Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.N Engl J Med2001; 345: 638–46.
8.
MarrR., BirbeckK., GarvicanJ.The modern abdominoperineal excision: the next challenge after total mesorectal excision.Ann Surg2005; 242: 74–82.
9.
ScottN., JacksonP., al-JaberiT.Total mesorectal excision and local recurrence: a study of tumour spread in the mesorectum distal to rectal cancer.Br J Surg1995; 82: 1031–3.
10.
PoonR.T., ChuK.W., HoJ.W.Prospective evaluation of selective defunctioning stoma for low anterior resection with total mesorectal excision.World J Surg1999; 23: 463–7, discussion 467–8.
11.
BuchsN.C., GervazP., SecicM.Incidence, consequences, and risk factors for anastomotic dehiscence after colorectal surgery: a prospective monocentric study.Int J Colorectal Dis2008; 23: 265–2670.
12.
LawW.L., ChoiH.K., LeeY.M.Anastomotic leakage is associated with poor long-term outcome in patients after curative colorectal resection for malignancy.J Gastrointest Surg2007; 11: 8–15.
13.
HuserN., MichalskiC.W., ErkanM.Systematic review and meta-analysis of the role of defunctioning stoma in low rectal cancer surgery.Ann Surg2008; 248: 52–60.
14.
LinJ.K., YuehT.C., ChangS.C.The influence of fecal diversion and anastomotic leakage on survival after resection of rectal cancer.J Gastrointest Surg2011; 15: 2251–61.
15.
SmithJ.D., PatyP.B., GuillemJ.G.Anastomotic leak is not associated with oncologic outcome in patients undergoing low anterior resection for rectal cancer.Ann Surg2012; 256(6): 1034–8.
16.
PatelJ.A., FleshmanJ.W., HuntS.R.Is an elective diverting colostomy warranted in patients with an endoscopically obstructing rectal cancer before neoadjuvant chemotherapy?Dis Colon Rectum2012; 55: 249–55.
17.
KuoL.J., LiuM.C., JianJ.J.Is final TNM staging a predictor for survival in locally advanced rectal cancer after pre-operative chemoradiation therapy?Ann Surg Oncol2007; 14: 2766–72.
18.
Habr-GamaA., PerezR.O., NadalinW.Long-term results of preoperative chemoradiation for distal rectal cancer correlation between final stage and survival.J Gastrointest Surg2005; 9: 90–9, discussion 99–101.
19.
DasP., SkibberJ.M., Rodriguez-BigasM.A.Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer.Am J Clin Oncol2006; 29: 219–24.
